tetrakis(acetoxymercuri)methane: reagent for labeling sulfur in nucleic acids [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 16683093 |
| SCHEMBL ID | 1310117 |
| MeSH ID | M0066989 |
| Synonym |
|---|
| mercury, tetrakis(acetato)-.mu.4-methanetetrayltetra- |
| nsc-150867 |
| mercury, tetrakis(acetato-o)-.mu.4-methanetetrayltetra- |
| nsc150867 |
| 25201-30-3 |
| SCHEMBL1310117 |
| unii-vcg6x60hjw |
| mercury, tetrakis(acetato)-mu4-methanetetrayltetra- |
| tetrakis(acetoxymercuri)methane |
| vcg6x60hjw , |
| mercury, tetrakis(acetato-o)-mu4-methanetetrayltetra- |
| nsc 150867 |
| DTXSID60179867 |
| mfcd00049094 |
| tetrakis(acetato-.kappa.o)-.mu.4-methanetetrayltetramercury |
| mercury, tetrakis(acetato-.kappa.o)-.mu.4-methanetetrayltetra- |
| acetyloxy-[tris(acetyloxymercurio)methyl]mercury |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| loviride | 1995 | 1995 | 29.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |||
| uridine triphosphate | pyrimidine ribonucleoside 5'-triphosphate; uridine 5'-phosphate | Escherichia coli metabolite; mouse metabolite | 1992 | 1992 | 32.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | |
| valine | L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 1978 | 1978 | 46.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 | |
| gold | copper group element atom; elemental gold | 1996 | 1996 | 28.0 | medium | 0 | 0 | 1 | 0 | 0 | 0 | ||
| thiouracil | nucleobase analogue; thiocarbonyl compound | antithyroid drug; metabolite | 1978 | 1978 | 46.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 | |
| thioguanine anhydrous | 2-aminopurines | anticoronaviral agent; antimetabolite; antineoplastic agent | 1978 | 1978 | 46.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 | |
| sulfur | chalcogen; nonmetal atom | macronutrient | 1978 | 1978 | 46.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|